Scilex CEO, Jaisim Shah, anticipates that strategic transact...
Scilex CEO, Jaisim Shah, anticipates that strategic transactions with Perigrove's portfolio companies will boost Scilex's commercial standing. He also expects an improved cash position and reduced reliance on future capital raising. Perigrove's CEO, David Gefner, is excited to support Scilex's growth in non-opioid pain management medicines.
Press Release: Scilex Holding Company Announces 5-Year Term of $100 Million Financing With Royalty-Based Payments and Potential Strategic Transactions With Perigrove and Its Portfolio Companies
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3995Followers
0Following
8972Visitors
Follow